A Repair Cream's 30-Second Effect After Laser Treatment, Measured in a Split-Face Trial

A post-laser repair cream built on three active ingredients, dexpanthenol, recombinant human fibronectin peptide, and Coreopsis tinctoria extract, has produced measurable changes in skin barrier function within minutes of application, according to a split-face trial published in the Journal of Cosmetic Dermatology.

The study, led by Qiaoyuan Liu and colleagues, enrolled 33 women with sensitive, barrier-impaired skin who underwent full-face treatment with a 1565-nm non-ablative fractional laser, a device that heats the dermis while leaving the surface layer of skin largely intact. That approach limits visible downtime but still triggers redness, swelling, and a temporarily weakened barrier in the hours after treatment.

Researchers designed the trial around a gap they identified in existing post-laser care research: most studies track recovery over days or weeks, leaving the first two hours after treatment largely undocumented with objective measurements. To fill that window, one side of each participant's face received the repair cream while the other side was left untreated, and the team tracked transepidermal water loss, hydration, redness, blood flow, and surface temperature at intervals as short as 30 seconds.

The results point to a rapid, if modest, effect. The treated side showed a 4.63% reduction in water loss at 30 seconds and a 3.94% reduction at two hours, alongside an 89.76% jump in hydration at the 30-second mark. By 10 minutes, the cream had reduced redness by 5.96%, blood perfusion by 17.85%, and surface temperature by 2.15%, with all differences reaching statistical significance.

For longer-term use, the trial shifted to a different comparison: the repair cream against a standard-care product, each applied to one side of the face over 14 days. On the cream side, water loss dropped by 4.34% compared with 1.12% on the comparator side. Ultrasound imaging also found skin thickness increasing by 12.67% versus 6.62%, and skin density rising by 17.70% versus a near-flat 0.15% on the comparator side.

Those density and thickness figures come from ultrasonographic measurement of the dermis, not surface photography, which the authors note addresses a second shortcoming in prior post-laser skincare research: a reliance on subjective or purely superficial endpoints rather than measurements of the deeper skin layers that laser energy actually targets.

No adverse events were reported during the trial, according to the published results. The authors frame the formula as a post-procedure care option specifically for sensitive-skin populations undergoing fractional laser treatment, a group for whom the standard advice to simply moisturize and wait has lacked much quantitative backing until now.

The trial was single-center and investigator-blind rather than fully blinded, and the sample was limited to 33 female participants, details that matter for anyone trying to judge how far the percentage gains reported in the abstract will travel to a broader population or a different laser setting. For now, the data describe one cream, one laser, and one carefully measured 14-day window.